Proactive Investors - Run By Investors For Investors

Kromek secures two new contracts for its medical division

Dr Arnab Basu, chief executive of Kromek Group PLC (LON:KMK), tells Proactive's Andrew Scott their medical division has won two contracts worth a combined US$1mln.

Basu says an equipment manufacturing customer's placed a US$700,000 order for their cadmium zinc telluride (CZT) detectors to be used in nuclear medicine.

Meanwhile in the bone mineral densitometry market they've received a repeat contract of $340,000 for CZT-based detectors.

 
Meet Yellow Cake PLC, Avation PLC, Manolete Partners PLC and Crossword Cybersecurity Plc at our event, London , 05 September 2019. Register here »
View full KMK profile View Profile

Kromek Group PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use